Ellipses Pharma
Ellipses Pharma is a United Kingdom-based biotechnology company running 3 late-stage cancer trials of EP0031, EP0042 and Azacitidine (AZA) in non-small-cell lung cancer, acute myeloid leukaemia and myelodysplastic syndromes / neoplasms.
Overview
Ellipses Pharma, based in London, the United Kingdom, is a biotechnology company. Ellipses Pharma is a London-based drug development company that advances a portfolio of in-licensed oncology drug candidates through clinical trials. On ClinicalTrials.gov it is the lead sponsor of 3 recruiting or active phase 2 and phase 3 interventional cancer trials, testing EP0031, EP0042, Azacitidine (AZA) and EP0062 in non-small-cell lung cancer, acute myeloid leukaemia, myelodysplastic syndromes / neoplasms and HR-positive / HER2-negative breast cancer. The largest, NCT05443126 (A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies), plans to enrol 265 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.
Scorecard
All companies- phase 1/2 +2
- targets +4
- modalities +2
EP0031 is an experimental small-molecule drug from Ellipses Pharma in phase 2 trials for non-small-cell lung cancer, aimed at RET.
EP0062 is an experimental small-molecule drug from Ellipses Pharma in phase 2 trials for HR-positive / HER2-negative breast cancer, aimed at Androgen receptor.
Similar pages
not linked directly; found by shared links- CompanyTreadwell Therapeutics
Shares Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia, HR-positive / HER2-negative breast cancer and the tag ctgov-sponsor.
- CompanyOrca Biosystems
Shares Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia and the tag ctgov-sponsor.
- CompanyShenzhen TargetRx
Shares Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyRyvu Therapeutics
Shares Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia and the tag ctgov-sponsor.
- CompanyMolecular Partners
Shares Acute myeloid leukaemia, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyMBrace Therapeutics
Shares HR-positive / HER2-negative breast cancer, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyShenzhen Ionova Life Sciences
Shares HR-positive / HER2-negative breast cancer, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyXuanzhu Biopharmaceutical
Shares HR-positive / HER2-negative breast cancer, Non-small-cell lung cancer and the tag ctgov-sponsor.